Aids in the diagnosis and follow-up of medullary thyroid carcinoma and in the evaluation of multiple endocrine neoplasia type II and familial medullary thyroid carcinoma.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. As soon as possible, centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells, aliquot into a plastic transport vial, and freeze.
Useful in the diagnosis and monitoring of a wide range of disorders including diseases of bone, kidney, parathyroid gland, or gastrointestinal tract Calcium levels may also reflect abnormal vitamin D or protein levels.
Serum
SST (1)
Plasma
Green (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for assessing calcium states during liver transplantation surgery, cardiopulmonary bypass, or any procedure requiring rapid transfusion of whole blood in neonates and critically ill patients. Also useful as a second-order test in the evaluation of patients with abnormal calcium values.
Useful for evaluation of patients suspected of having a gastrointestinal inflammatory process and distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS) when used in conjunction with other diagnostic modalities, including endoscopy, histology, and imaging.
Useful for evaluating patients' response to ovarian cancer therapy and Predicting recurrent ovarian cancer. Not useful for cancer detection screening in the normal population.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
REFRIGERATE (72 Hours)
4 Days
Chemiluminescence
86304
CA125, Carbohydrate Antigen 125, OV Monitor, Ovarian Cancer-Related Antibodies, Cancer Ag 125, CA 125
Aides in managing breast cancer patients when used in conjunction with clinical information and other diagnostic procedures. Serial testing can assist in early detection of disease recurrence in previously treated stage II and III breast cancer patients. Also useful for monitoring response to therapy in metastatic breast cancer patients
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Dietary Restrictions: Avoid Biotin (B7) for 12 HR Prior
REFRIGERATE (7 Days)
4 Days
Electrochemiluminescence Immunoassay (ECLIA)
86300-90
CA 15-3, CA153, MUC-1, Mucin-Like Carcinoma-Associated Antigen
Useful to establish the diagnosis of an allergic disease and to define the allergens responsible for eliciting signs and symptoms. May also be used to identify allergens which may be responsible for allergic disease and/or anaphylactic episode, to confirm sensitization to particular allergens prior to beginning immunotherapy, and to investigate the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
IgE antibodies may be useful to establish the diagnosis of an allergic disease and to define the allergens responsible for eliciting signs and symptoms. Testing also may be useful to identify allergens which may be responsible for allergic disease and/or anaphylactic episode, to confirm sensitization to particular allergens prior to beginning immunotherapy, and to investigate the specificity of allergic reactions to allergens, drugs, or chemical allergens.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for monitoring carbamazepine (free) therapy in uremic patients, and for monitoring unbound or free carbamazepine levels in patients where the total carbamazepine result is within the therapeutic range but the patient is experiencing side effects.
Potentially useful adjunct for diagnosis and monitoring of pancreatic cancer. May be useful for differentiating patients with cholangiocarcinoma and primary sclerosing cholangitis (PSC) from those with PSC alone.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
FREEZE (14 Days)
4 Days
Chemiluminescence
86301-90
CA 19-9, Cancer Antigen 19-9, Carbohydrate Antigen 19-9, GI Cancer Antigen
Useful for monitoring colorectal cancer and selected other cancers such as medullary thyroid carcinoma. May be useful in assessing the effectiveness of chemotherapy or radiation treatment, but is not useful in screening the general population for undetected cancers.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Testing for cardiolipin (phospholipid) antibodies is indicated in the following clinical situations: Unexplained arterial or venous thrombosis, a history of pregnancy morbidity defined as 1 or more unexplained deaths of a morphologically normal fetus beyond the 10th week of gestation, 1 or more premature births before 34 weeks of gestation caused by severe preeclampsia or placental insufficiency, or 3 or more unexplained, consecutive spontaneous abortions before the 10th week of gestation with no identifiable maternal hormonal or anatomic, or maternal or paternal chromosomal causes. Useful in the presence of an unexplained cutaneous circulatory disturbance (eg, livido reticularis or pyoderma gangrenosum), in the presence of an unexplained cutaneous circulatory disturbance (eg, livido reticularis or pyoderma gangrenosum). Also useful in the presence of a systemic rheumatic disease (especially lupus erythematosus), an unexplained thrombocytopenia or hemolytic anemia, and possible nonbacterial thrombotic endocarditis.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for the evaluation of patients with suspected antiphospholipid syndrome by identification of phospholipid antibodies.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful in the evaluation of patients with a clinical suspicion of a wide range of conditions including organic acidemias, fatty acid oxidation disorders, and primary carnitine deficiency.
Plasma
Green (1) Sodium OR Lithium Heparin
Plastic Transport Vial
0.5 mL
Serum
Red (1)
Centrifuge and aliquot plasma into plastic transport vial within 2 hours of collection and freeze promptly. Submit frozen plasma in plastic transport vial.
Useful as an auxiliary test to fractionated plasma and urine metanephrine measurements in the diagnosis of pheochromocytoma and paraganglioma. Also used as an auxiliary test to urine vanillylmandelic acid and homovanillic acid determination in the diagnosis and follow-up of patients with neuroblastoma and related tumors.
Urine
24 Hour Urine Jug (1)
None
None
Avoid drugs that hinder metabolism of epinephrine or dopamine for at least 1 week prior to draw, if possible.
Useful in the diagnosis of pheochromocytoma and paraganglioma, as an auxiliary test to fractionated plasma and urine metanephrine measurements (plasma metanephrine is the preferred test for this diagnosis), in the diagnosis and follow-up of patients with neuroblastoma and related tumors, as an auxiliary test to urine vanillylmandelic acid and homovanillic acid measurements, and in the evaluation of patients with autonomic dysfunction or failure or autonomic neuropathy.
Plasma
Green (2) Sodium Heparin ICED CRITICAL FROZEN
None
None
Draw in chilled vacutainer and place immediately into ice bath. Send 4.0 mL plasma CRITICAL FROZEN in two vials.
FREEZE (30 Days)
8 Days
High Performance Liquid Chromatography with Electrochemical Detection
Useful as a screening tool to confirm a hematologic disorder, detection of an unsuspected hematologic disorder, and/or to monitor effects of radiation or chemotherapy.
Useful as a screening tool to confirm a hematologic disorder, detection of an unsuspected hematologic disorder, and/or to monitor effects of radiation or chemotherapy.
Useful for evaluating patients suspected of having rheumatoid arthritis (RA) and for differentiating RA from other connective tissue diseases that may present with arthritis.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful in serial monitoring of CD4 T cell count in HIV-positive patients, for follow-up and diagnostic evaluation of primary cellular immunodeficiencies (including severe combined immunodeficiency), for T-cell immune monitoring following immunosuppressive therapy for transplantation, autoimmunity, and other immunological conditions where such treatment is utilized. Also used in the assessment of T-cell immune reconstitution post hematopoietic cell transplantation, and in early screening of gross quantitative anomalies in T cells in infection or malignancies.
Whole Blood
EDTA (2)
None
None
Send 4.0 mL whole blood within 24 HR of draw. Serial monitoring draws should be performed at same time of day.
RT (72 Hours)
3 Days
Flow Cytometry, Single Platform
86359, 86360
CD4 Count, Immune Competence, Immune Status, Quantitative CD4, T Cell(s), T-Cell(s), T Lymphocyte Surface Markers, T-Cell Surface Markers, T-Helper, AIDS (Acquired Immune Deficiency Syndrome)
Useful for determining ratio of CD4 to CD8 cells to evaluate immune strength and predict infection in HIV, leukemia, aplastic anemia, MS, myasthenia graves, and Hodgkin diseases.
Whole Blood
EDTA (2)
None
None
Send 4.0 mL whole blood. Collect MON-THURS only, do not send Friday.
RT (72 Hours)
4 Days
Flow Cytometry
86360
CD4 Count, CD8 Count, Helper Suppressor Ratio, Immune Competence, Immune Status, Immunodeficiency Panel, Quantitative CD4 and CD8, T Cell(s), T-Cell(s), T Lymphocyte Surface Markers, T-Cell Surface Markers, T-Helper/T-Suppressor, T4/T8 Helper Suppressor Ratio, AIDS (Acquired Immune Deficiency Syndrome)
Useful for evaluating patients suspected of having celiac disease, including patients with compatible symptoms, patients with atypical symptoms, and individuals at increased risk (family history, previous diagnosis with associated disease, positivity for DQ2 and/or DQ8).
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful in evaluating patients with clinical signs and symptoms compatible with systemic sclerosis including skin involvement, Raynaud phenomenon, and arthralgias. Useful in aiding in the diagnosis of calcinosis, Raynaud phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasis (CREST) syndrome.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for investigation of patients with possible Wilson disease.
Serum
SST (1)
Plasma
EDTA (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for evaluation of water, electrolyte, and acid-base status
Serum
SST (1)
Plasma
Green (1) Lithium Heparin
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful to determine if you have been exposed to and/or poisoned by certain organophosphate chemicals found in pesticides, to monitor cholinesterase levels if you work with pesticides, or to identify individuals with inherited pseudocholinesterase deficiency before they are given anesthesia with the muscle relaxant succinylcholine. Can also help determine the cause of prolonged apnea after surgical anesthesia.
Useful for the follow-up or surveillance of patients with known or treated carcinoid tumors, as an adjunct in the diagnosis of carcinoid tumors, as an adjunct in the diagnosis of other neuroendocrine tumors (including pheochromocytomas, medullary thyroid carcinomas, functioning and nonfunctioning islet cell and gastrointestinal amine precursor uptake and decarboxylation tumors, and pituitary adenomas), and as a possible adjunct in outcome prediction and follow-up in advanced prostate cancer
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful in diagnosis of heart attack, finding the cause of chest pain, or finding out how much heart or muscle tissue has been damaged. Can also determine whether you carry the gene for muscular dystrophy including dermatomyositis, polymyositis, malignant hyperthermia, and other conditions that may cause muscle breakdown.
Serum
SST (1)
None
None
Pour Off Within 4HR
REFRIGERATE (7 Days)
6 Days
Electrophoresis/Spectrophotometry
82550, 82552
CK (Creatine Kinase), CK Isoenzyme Electrophoresis, CK Macro, CK-BB, CK-MM, CPK (Creatine Phosphokinase), Isoenzyme of Creatine Kinase, Macro CK, Macro Creatine Kinase, Mitochondrial Creatine Kinase, CPK Isoenzyme Electrophoresis
Useful for the diagnosis and treatment of acid-base imbalance in respiratory and metabolic systems
Serum
SST (1)
Plasma
Green (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for diagnosing deficiencies, particularly hemophilia B (Christmas disease), assessing the impact of liver disease on hemostasis, and investigation of a prolonged activated partial thromboplastin time.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
FREEZE (14 Days)
4 Days
Optical Clot-Based
85250
Factor IX Activity Assay, Hemophilia B, Factor IX, Factor 9
Useful for diagnosing congenital deficiencies of coagulation factor V, investigation of prolonged prothrombin time or activated partial thromboplastin time, and evaluating acquired deficiencies associated with liver disease, factor V inhibitors, myeloproliferative disorders, and intravascular coagulation and fibrinolysis.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
Useful for diagnosing congenital deficiency of coagulation factor VII and evaluating acquired deficiencies associated with liver disease, oral anticoagulant therapy, and vitamin K deficiency. Also useful for determining degree of anticoagulation with warfarin to correlate with level of protein C, and for investigation of a prolonged prothrombin time.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
FREEZE (14 Days)
4 Days
Optical Clot-Based
85230
Coagulation Factor VII Assay, FACTOR VII ACTIVITY, Prothrombin, Factor VII, Factor 7
Useful in the diagnosing hemophilia A, the diagnosis of von Willebrand disease when measured with the von Willebrand factor (VWF) antigen and VWF activity, and the diagnosing acquired deficiency states. Also useful in the investigation of prolonged activated partial thromboplastin time, and in monitoring infusions of factor VIII replacement during interventional procedures and prophylactic infusions.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
FREEZE (14 Days)
4 Days
Optical Clot-Based
85240
Coagulation Factor VIII Activity Assay, Factor VIII Activity Assay, Hemophilia A, Factor VIII, Factor 8
Useful for diagnosing deficiency of coagulation factor X (congenital or acquired), in evaluating hemostatic function in liver disease, and in the investigation of prolonged prothrombin time or activated partial thromboplastin time.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
Useful in diagnosing deficiency of coagulation factor XI, and investigation of prolonged activated partial thromboplastin time
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
FREEZE (14 Days)
4 Days
Optical Clot-Based
85270
Factor XI Activity Assay. F11, Factor XI, Factor 11
Useful for diagnosing deficiency of coagulation factor XII, and for determining cause of prolonged activated partial thromboplastin time.
Plasma
Lt. Blue (1)
None
None
Centrifuge collection tube for 15 minutes to seperate plasma from red cells. Using a pipette, aliquot all available plasma into a plastic transport vial. Centrifuge transport vial again and pipette all but the bottom 0.25 mL of plasma into a seperate transport vial and freeze. Must be dedicated specimen.
PT must not be on Coumadin or heparin therapy. Spin TWICE and pour off within 4 HR of collection. CRITICAL FROZEN.
FREEZE (14 Days)
4 Days
Optical Clot-Based
85280
Coagulation Factor XII Activity Assay, Factor XII, Factor 12
Useful for detecting cobalt toxicity and monitoring metallic prosthetic implant wear.
Serum
Dark Blue Trace Element (1)
Plasma
Dark Blue EDTA (1)
Invert tube 10 times immediately post-draw. Within 2 hours of draw, centrifuge collection tube for 15 minutes to seperate plasma from red cells. Without using a pipette, gently pour-off all possible plasma into a metal-free transport vial. Leave ambient at room temperature.
Discontinue vitamin, mineral, herbal supplements, and an non-essential medications prior to draw. USE METAL FREE POUR OFF TUBE.
RT
9 Days
Quantitative Inductively Coupled Plasma - Mass Spectrometry
Useful when used to evaluate or monitor the rate of bone formation and resorption. It is a useful tool to detect the presence of Paget disease and monitor the progress of osteoporosis. Typically ordered when there could be the presence of a metabolic bone disease.
Useful when assessing disease activity in systemic lupus erythematosus (SLE) and/or investigating an undetectable total complement (CH50) level.
Serum
SST (1)
Plasma
EDTA (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
REFRIGERATE (8 Days)
4 Days
Nephelometry
86160
3rd Component of Complement, C3 COMP, C3, Third Component of Complement
Useful when investigating an undetectable total complement (CH50), confirming hereditary angioedema (with low C1 inhibitor), and for assessing disease activity in systemic lupus erythematosus, proliferative glomerulonephritis, rheumatoid arthritis, and autoimmune hemolytic anemia.
Serum
SST (1)
Plasma
EDTA (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
REFRIGERATE (8 Days)
4 Days
Nephelometry
86160
4th Component of Complement, C4, Fourth Component of Complement, Hereditary Angioedema Panel
Broad screening tool to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Used to monitor known conditions, such as hypertension, and to monitor people taking specific medications for any kidney or liver-related side effects.
Serum
SST (1)
Plasma
Green (1) Lithium Heparin
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Broad screening tool to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Used to monitor known conditions, such as hypertension, and to monitor people taking specific medications for any kidney or liver-related side effects.
Serum
SST (1)
Plasma
Green (1) Lithium Heparin
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Fasting Preferred (12 HR)
REFRIGERATE (7 Days)
Various (See individual test methodology)
80053
CMPC, CMP with calcs, Chemistry Panel with Calculations, Chemistry Screen with Calculations
Useful when discriminating between primary and secondary adrenal insufficiency and in the differential diagnosis of Cushing syndrome.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
The preferred screening test for Cushing Syndrome. Useful in the diagnosis of pseudo-hyperaldosteronism due to excessive licorice consumption. Assists in the diagnosis of acquired or inherited abnormalities of 11-beta-hydroxy steroid dehydrogenase. This test has limited usefulness in the evalution of adrenal insufficiency.
Urine
Sterile Container (1)
None
None
FREEZE (28 Days)
6 Days
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Useful in a diagnostic workup of hypoglycemia through diagnosis of factitious hypoglycemia due to surreptitious administration of insulin, in the evaluation of possible insulinoma, and as a surrogate measurement for the absence or presence of physiological suppressibility of endogenous insulin secretion during diagnostic insulin-induced hypoglycemia (C-peptide suppression test). Also useful for assessing insulin secretory reserve in diabetic patients who either have insulin autoantibodies or who are receiving insulin therapy.
Creatine kinase is utilized in the diagnosis and monitoring of myocardial infarction and myopathies such as the progressive Duchenne muscular dystrophy.
Serum
SST (1)
Plasma
Green (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful in the risk assessment for developing myocardial infarction in patients presenting with acute coronary syndromes, and in the risk assessment for developing cardiovascular disease or ischemic events in individuals who do not manifest the disease at present.
Serum
SST (1)
NONE
NONE
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
REFRIGERATE (7 Days)
Turbidimetric/Immunoturbidimetric
86141
C Reactive Protein Cardiac, C Reactive Protein High Sensitivity, C-Reactive Protein Cardio, C-Reactive Protein Sensitive, CRP Cardiac, CRP Highly Sensitive, CRP Ultra-Sensitive, Sensitive C-Reactive Protein, Ultra-Sensitive C-Reactive Protein, CRPC, HSCRP
Useful for estimation of glomerular filtration rate.
Serum
SST (1)
Plasma
EDTA (1)
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for detecting systemic inflammatory processes, for detecting infection and assessing response to antibiotic treatment of bacterial infections, and for differentiating between active and inactive disease forms with concurrent infection.
Serum
SST (1)
NONE
NONE
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for evaluating cryoglobulins in patients with vasculitis, glomerulonephritis, and lymphoproliferative diseases, and in evaluating patients with macroglobulinemia or myeloma in whom symptoms occur with cold exposure.
Serum
Red (1) Clot in Warm Water
None
None
Allow sample to clot in warm water before serum is spun and separated from cells.
Useful for monitoring whole blood cyclosporine concentration during therapy (particularly in individuals coadministered CYP3A4 substrates, inhibitors, or inducers), for adjusting dose to optimize immunosuppression while minimizing toxicity, and fort evaluating patient compliance.
Whole Blood
EDTA (1)
None
None
Draw immediately before scheduled dose. DO NOT centrifuge. Send in original collection tube.
REFRIGERATE (14 Days)
2 Days
High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS)
Aiding in the diagnosis of acute or past infection with cytomegalovirus (CMV) and determination of prior exposure to CMV.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Aiding in the diagnosis of acute infection with cytomegalovirus (CMV).
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for the detection and quantification of cytomegalovirus (CMV) viremia, and for monitoring CMV disease progression and response to antiviral therapy.
Plasma
EDTA (1)
None
None
DEDICATED SPECIMEN REQUIRED. Centrifuge and separate within 24 hours.
REFRIGERATE (5 Days)
4 Days
PCR
87497
Cytomegalovirus detection by PCR, CMV by PCR, CMV DNA Quant, CMV Viral Load
Determining whether a patient (especially transplant recipients, organ, and blood donors) has had a recent infection or previous exposure to cytomegalovirus.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).
Useful for evaluating patients suspected of having autoimmune vasculitis (both Wegener granulomatosis [WG] and microscopic polyangiitis). May be useful for monitoring treatment response in patients with WG (systemic or organ-limited disease); increasing titer suggests relapse of disease, while a decreasing titer suggests successful treatment.
Serum
SST (1)
None
None
Allow SST tube to clot for at least 15 minutes post-draw. Centrifuge unopened collection tube(s) for 15 minutes to separate serum from red cells. Submit unopened collection tube(s).